Core Viewpoint - The report from Guojin Securities indicates a differentiated performance in the light industry manufacturing sector, with home furnishings and paper sectors stabilizing at the bottom, while new tobacco and packaging sectors show a steady upward trend. The trendy toy sector is showing positive signals of recovery, whereas the light consumer goods sector is under pressure [1]. Group 1: Home Furnishings - The central economic work conference continues to focus on "boosting consumption and expanding domestic demand," with upcoming actions to stimulate consumption, benefiting home furnishings demand recovery [2]. - In November, China's furniture export value decreased by 8.83% year-on-year, but the decline has narrowed to single digits. Exports to Southeast Asia are steadily increasing, while exports to the U.S. are showing a mild downward trend [2]. - The report suggests that while domestic demand remains weak in the short term, it is expected to recover steadily due to supportive consumption policies. Companies with strong brand attributes and operational advantages are recommended [2]. Group 2: New Tobacco - In the vaping sector, 18 states in the U.S. have implemented regulations, covering about 50% of the industry's tracked channel sales, which is expected to support sales recovery for compliant brands like Vuse [3]. - The report highlights that as enforcement against illegal vaping products strengthens, the compliant market is likely to expand, benefiting leading brands [3]. - The FDA has approved ON!Plus nicotine pouches, marking a significant regulatory milestone for the nicotine pouch market [3]. Group 3: Paper and Packaging - As of December 18, domestic prices for needle and broadleaf pulp were 5542 and 4633 yuan per ton, respectively, with a slight increase from the previous week. The report notes a continuous decline in inventory levels, indicating tightening supply and rising prices [4]. - The report indicates that downstream packaging demand is steadily recovering, which is expected to support the performance of packaging companies [4]. - The acquisition of Zhongliang Packaging by Aorijin has significantly increased market concentration in the two-piece can industry, enhancing overall pricing power [4]. Group 4: Light Consumer Goods - The light consumer goods sector is experiencing heightened competition, with a clear demand-driven focus and increasing brand concentration. The report highlights top brands in the toothpaste market, indicating a shift towards efficacy and e-commerce adaptability [5]. - Companies with strong new product capabilities and robust offline channel growth logic are recommended for investment [5]. Group 5: Trendy Toys - The trendy toy industry is transitioning from rapid IP growth to a phase of deep cultivation and international expansion. Leading companies like Pop Mart are actively launching new products and expanding their market presence [7]. - The report emphasizes the importance of focusing on leading companies and traditional firms that are successfully transforming their IP development strategies [7]. Group 6: Investment Recommendations - Recommended companies in the home furnishings sector include Oppein Home, Sophia, and Mousse Holdings. In the new tobacco sector, recommended companies include Smoore International and China Tobacco Hong Kong [8]. - For light consumer goods, companies like Pop Mart and Morning Glory are highlighted, while in the paper and packaging sector, Yutong Technology and Sun Paper are recommended [8].

Investment Rating - The report suggests a cautious optimism for the home furnishing sector, with a recommendation to prefer leading companies with clear dividend attributes and retail transformation advantages [4][9]. Core Insights - The home furnishing sector is experiencing weak demand, with a significant decline in property transactions, but government policies aimed at boosting consumption are expected to support gradual recovery [4][9]. - The new tobacco sector shows signs of stabilization and growth, particularly in the vapor segment, supported by regulatory actions against illegal products [10][11]. - The paper and packaging industry is witnessing price increases due to tightening supply and recovering demand, indicating potential for price recovery in finished paper products [11][12]. - The light consumer goods and trendy toys sectors are showing growth, with domestic brands outperforming foreign ones in certain categories [13][14]. Summary by Sections Home Furnishing Sector - Domestic sales are under pressure, with a year-on-year decline of 36.29% in new home transactions and 38.19% in second-hand home transactions as of December 12 [4][9]. - Government initiatives to stimulate consumption are expected to positively impact home furnishing demand recovery [4][9]. - Export data shows a decline of 8.83% in furniture exports from China, while Vietnam's furniture exports increased by 8.59% [4][9]. New Tobacco Sector - The vapor segment is seeing regulatory support, with 18 states in the U.S. implementing vapor product regulations, which is expected to enhance sales for compliant brands like Vuse [10][11]. - The heated tobacco segment is experiencing increased promotional efforts, with expectations for significant growth by 2026 [10][11]. Paper and Packaging Sector - Prices for needle and broadleaf pulp have increased, with current prices at 5502 and 4605 RMB per ton respectively, indicating a tightening supply situation [11][12]. - Packaging materials are also seeing price increases, with boxboard and corrugated paper prices rising by 7.46% and 13.71% respectively since August [12]. Light Consumer Goods and Trendy Toys - The toothpaste segment saw a 13% increase in online sales, while sanitary napkins experienced a modest 1.2% growth [13][24]. - The trendy toy sector is thriving, with online sales growth of 10%, and specific categories like blind box dolls growing by 33% [14][24].

据BAT2025年业绩预告，日本市场上BAT积极推进线上线下营销活动，产品品牌和性能引起消费者的强 烈共鸣，来自传统卷烟和加热烟草消费者的留存率约为50%。高留存率直接验证hilo优秀的产品力，为 后续烟弹起量奠定坚实基础。据BAT官网，近期hilo于波兰市场上大幅提高优惠力度，Hilo器具加两包 烟弹仅售1兹罗提，Hilo Plus器具加两包烟弹仅售79兹罗提。依托BAT完备的销售网络和足够的营销资 源，后续Hilo烟弹销售有望持续放量，为思摩尔贡献核心盈利增量。 核心雾化业务持续修复，有望持续受益于欧美市场扩容 智通财经APP获悉，国金证券发布研报称，思摩尔国际(06969)作为头部烟草巨头核心供应商，且自营的 开放式产品持续贡献业绩增量，有望充分受益于欧美合规雾化市场扩容。海外新型烟草渗透率提升的长 期趋势确定，公司依托自身技术实力、量产能力深度绑定大烟草集团享受产业发展大趋势的优势地位突 出。公司雾化、HNB业务向上的趋势没有变化，各项业务积极信号正不断涌现，建议积极关注，维 持"买入"评级。 国金证券主要观点如下： 事件简评 12月11日，公司公告称，为推进股权激励计划，公司于12月11日购买814 ...

Core Viewpoint - Guojin Securities maintains a "Buy" rating for Smoore International (06969), projecting EPS for 2025-2027 to be 0.22, 0.39, and 0.59 yuan respectively, with current stock prices corresponding to PE ratios of 67, 37, and 25 times [1] Financial Performance - For Q1-Q3 2025, the company achieved revenue of 10.21 billion yuan, a year-on-year increase of 21.8%, with net profit and adjusted net profit (excluding stock incentive costs) at 808 million and 1.182 billion yuan, reflecting a year-on-year decrease of 23.8% and an increase of 0.1% respectively [1] - In Q3 2025, the company reported revenue of 4.197 billion yuan, a year-on-year increase of 27.2%, with net profit and adjusted net profit at 317 million and 444 million yuan, showing a year-on-year decrease of 16.4% and an increase of 4.0% respectively [1][2] Business Segments - The HNB (Heat-not-Burn) business is expected to significantly contribute to revenue, with the launch of the hilo product in Japan and Poland driving sales growth [1] - The vaping business is anticipated to achieve double-digit growth in Q3 2025, benefiting from regulatory changes in Europe and increased enforcement against illegal products in the U.S. [1] - The company is focusing on the iteration and expansion of its own brand series, with a steady increase in market share for its OBM (Own Brand Manufacturing) business [1] Profitability Outlook - The adjusted net profit for Q3 2025 increased by 4.0% to 444 million yuan, with an adjusted net profit margin of 10.6%, slightly down from 11.5% in Q3 2024 [2] - Despite a decline in profit margin, the overall performance remains strong, with future profit elasticity expected due to the anticipated increase in HNB business profitability as sales volume grows [2] Market Expansion - The expansion of the legal vaping market in Europe and the U.S. is a significant trend, with the HNB product glo hilo starting promotions in Poland, indicating potential for global sales growth [3] - The company is positioned as a unique player deeply involved in the supply chains of both vaping and HNB products, suggesting a clear path for future growth [3]

Core Viewpoint - The company reported a significant revenue increase in Q3 2025, driven by the HNB and vaping business, despite a decline in net profit due to initial low-margin sales and ongoing investments in R&D [1][2] Financial Performance - For Q1-Q3 2025, the company achieved revenue of 10.21 billion yuan, a year-on-year increase of 21.8%, with net profit of 809 million yuan, down 23.8% [1] - In Q3 2025, revenue reached 4.197 billion yuan, up 27.2% year-on-year, while net profit was 317 million yuan, a decrease of 16.4% [1] Business Analysis - The HNB business is expected to contribute significantly to revenue, with the HNB product "hilo" launched in Japan and Poland, leading to strong sales [1] - The vaping business is projected to see double-digit growth in Q3 2025, benefiting from regulatory changes in Europe and increased enforcement against illegal products in the U.S. [1] - The company is focusing on brand development and market expansion, with a steady increase in market share for its own brands [1] - The adjusted net profit for Q3 2025 showed a year-on-year increase of 4.0% to 444 million yuan, with an adjusted net profit margin of 10.6% [1] Growth Outlook - The expansion of the legal vaping market in Europe and the U.S. is expected to continue, with the HNB product "glo hilo" gaining traction in Poland [2] - The company is positioned uniquely in the market as a supplier in both vaping and HNB categories, indicating a strong growth potential [2] Earnings Forecast and Valuation - The company forecasts EPS of 0.22, 0.39, and 0.59 yuan for 2025-2027, with corresponding PE ratios of 67, 37, and 25 times [2]

Group 1 - The company reported Q3 2025 financial data, with revenue of 4.197 billion yuan, a year-on-year increase of 27.5%, and adjusted profit of 444 million yuan, a year-on-year increase of 4.8% [1] - HNB is expected to become a major growth driver, with significant revenue increase anticipated due to the pre-production nature and the full rollout of hilo in Japan, leading to substantial sequential growth in sales [1] - The ODM+ strategy has been further validated, with satisfactory growth from new product iterations, and overall growth expected to exceed double digits as new compliant products are launched [1] Group 2 - Emerging businesses are expected to elevate the company's valuation, with the subsidiary successfully submitting an ANDA for Breo Ellipta, which is used for asthma and COPD treatment, indicating potential for further valuation uplift [1] - The company anticipates that HNB will become a primary source of profit release by 2026, with traditional vaping business valuation solidifying [2] - Revenue projections for 2025-2027 are 14.2 billion, 16.9 billion, and 19.5 billion yuan, with corresponding net profits of 1.395 billion, 1.898 billion, and 2.368 billion yuan, leading to PE ratios of 64.53x, 47.44x, and 38.02x respectively, maintaining a "buy" rating [2]

Investment Rating - The investment rating for the company is "Buy" (maintained) [2] Core Insights - The company reported a significant revenue and profit increase in Q3 2025, with revenue reaching 4.197 billion yuan, a year-on-year growth of 27.5%, and adjusted profit of 444 million yuan, up 4.8% year-on-year [7] - The HNB (Heat Not Burn) segment is expected to become a major growth driver, with substantial sales growth anticipated in Japan and Europe [7] - The ODM+ strategy has shown satisfactory growth due to successful product iterations, with overall growth expected to exceed double digits [7] - The valuation of the company is expected to rise with the introduction of new compliant products and the recent FDA acceptance of a generic drug application for Breo® Ellipta® [7] - The company forecasts revenues of 14.2 billion, 16.9 billion, and 19.5 billion yuan for 2025, 2026, and 2027 respectively, with corresponding net profits of 1.395 billion, 1.898 billion, and 2.368 billion yuan [7] Financial Performance Summary - Revenue projections for the company are as follows: 11,168 million yuan in 2023, 11,799 million yuan in 2024, 14,200 million yuan in 2025, 16,900 million yuan in 2026, and 19,500 million yuan in 2027, with a revenue growth rate of 20.35% in 2025 [6][8] - The net profit forecast shows a decline in 2024 to 1,303 million yuan, followed by a recovery to 1,395 million yuan in 2025, and further growth to 1,898 million yuan in 2026 and 2,368 million yuan in 2027 [6][8] - The company's EPS is projected to be 0.23 yuan in 2025, 0.31 yuan in 2026, and 0.38 yuan in 2027, with corresponding PE ratios of 64.53x, 47.44x, and 38.02x [6][8]